Explore
Validate
LearnHPA017980
antibody from Atlas Antibodies
Targeting: SLC3A2
4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA017980 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA017980, RRID:AB_2669723
- Product name
- Anti-SLC3A2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SLC3A2, Gene description: solute carrier family 3 (amino acid transporter heavy chain), member 2, Alternative Gene Names: 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE, Validated applications: ICC, IHC, WB, Uniprot ID: P08195, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.4 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer
Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
Tombari C, Zannini A, Bertolio R, Pedretti S, Audano M, Triboli L, Cancila V, Vacca D, Caputo M, Donzelli S, Segatto I, Vodret S, Piazza S, Rustighi A, Mantovani F, Belletti B, Baldassarre G, Blandino G, Tripodo C, Bicciato S, Mitro N, Del Sal G
Nature Communications 2023;14(1)
Nature Communications 2023;14(1)
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer
Alfarsi L, El-Ansari R, Craze M, Masisi B, Mohammed O, Ellis I, Rakha E, Green A
International Journal of Molecular Sciences 2020;21(4):1407
International Journal of Molecular Sciences 2020;21(4):1407
Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes
Lane D, Bae D, Siafakas A, Suryo Rahmanto Y, Al-Akra L, Jansson P, Casero R, Richardson D
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864(9):2793-2813
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864(9):2793-2813
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
El Ansari R, Craze M, Diez-Rodriguez M, Nolan C, Ellis I, Rakha E, Green A
British Journal of Cancer 2018;118(8):1115-1122
British Journal of Cancer 2018;118(8):1115-1122
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human kidney and skeletal muscle tissues using HPA017980 antibody. Corresponding SLC3A2 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
